[Conservative therapy and prevention of diabetic macroangiopathy].
D000367:Age Factors; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy; D001161:Arteriosclerosis / Q000150:complications; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000517:prevention & control / Q000628:therapy*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D008297:Male; D009765:Obesity; D010806:Physical Education and Training; D012737:Sex Factors; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
Konservative Therapie und Prophylaxe der Macroangiopathia diabetica